|
CNTLN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6286971771251E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-15 |
| Normal-vs-Stage2 |
5.53289999999373E-05 |
| Normal-vs-Stage3 |
4.38990000000139E-05 |
| Normal-vs-Stage4 |
5.91949999999564E-05 |
| Stage1-vs-Stage2 |
9.588000E-01 |
| Stage1-vs-Stage3 |
8.944800E-03 |
| Stage1-vs-Stage4 |
1.155750E-02 |
| Stage2-vs-Stage3 |
1.026810E-01 |
| Stage2-vs-Stage4 |
1.172210E-01 |
| Stage3-vs-Stage4 |
9.396400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.29896093881143E-14 |
| Normal-vs-AfricanAmerican |
6.769800E-04 |
| Normal-vs-Asian |
8.824000E-03 |
| Caucasian-vs-AfricanAmerican |
4.770400E-01 |
| Caucasian-vs-Asian |
7.626500E-02 |
| AfricanAmerican-vs-Asian |
4.817900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.8008264030841E-12 |
| Normal-vs-Female |
4.91451324080572E-12 |
| Male-vs-Female |
1.420630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.222600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.30848673510309E-12 |
| Normal-vs-Age(61-80Yrs) |
7.69390107180357E-11 |
| Normal-vs-Age(81-100Yrs) |
3.035900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.824200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.012600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.799800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.899700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.110800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.945000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.226800E-04 |
| Normal-vs-Grade 2 |
1.62458935193399E-12 |
| Normal-vs-Grade 3 |
7.38810013167779E-10 |
| Normal-vs-Grade 4 |
1.082830E-01 |
| Grade 1-vs-Grade 2 |
3.178200E-01 |
| Grade 1-vs-Grade 3 |
6.441400E-03 |
| Grade 1-vs-Grade 4 |
5.85759999999214E-05 |
| Grade 2-vs-Grade 3 |
1.337070E-03 |
| Grade 2-vs-Grade 4 |
6.63179999804697E-08 |
| Grade 3-vs-Grade 4 |
2.204500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
1.199370E-03 |
| ccA subtype-vs-ccB subtype |
3.11650705242528E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.26252391558546E-12 |
| Normal-vs-N1 |
4.935800E-01 |
| N0-vs-N1 |
8.187600E-02 |
|
|
